نتایج جستجو برای: obesity agents

تعداد نتایج: 488578  

Journal: :Gaceta sanitaria 2012
Jorge V Pérez-Rodríguez Beatriz González López-Valcárcel

OBJECTIVE This study empirically analyzes the effects of public information about the pharmaceutical R&D process on the market valuation of the sponsoring firm. We examined the market's response to scientific news and regulatory decisions about an antiobesity drug, rimonabant, and the effects on the sponsoring company (Sanofi-Aventis) and its incumbent competitors (Abbott and Roche). METHODS ...

2016
L Carlsson P. Schauer Rubino* Francesco Nathan David M. Eckel Robert H. Schauer Philip R. Alberti K. George Zimmet Paul Z. Prato Stefano Del Ji Linong Sadikot Shaukat M. Herman William H. Amiel Stephanie A. Kaplan Lee M. Taroncher-Oldenburg Gaspar Cummings* David E. G Mingrone G Schernthaner K. Johansson F Pattou DB. Sarwer JJ. Holst R. Taylor T. Goldstone R. Stancliffe J.E. Blundell H. Roche N Sattar S. Enerbäck W. Lichtenbelt van Marken E. Sanguinetti D. Panetta M. Tripodi S. Burchielli PA. Salvadori P. Lozzo E. Norén H. Forssell K. Heisler L. K. Hall A. Bosy-Westphal R. Pandit A. Omrani M. Luijendijk S. Hoek L. Eggels V. de Vrind K. Neijs Rozen AJ. Van Fleur SE. la R. Adan JA. Chowen C. Benedict A. Rodríguez M. Hassapidou M. de Zwaan S. Feller A. Müller A. Mayr S. Engeli A. Hilbert J. Stubbs T. Reinehr H. Szajewska M. Golan F. Bäckhed K. Clément M. Nieuwdorp J. Jensen O. Allais E. Haynes P. Glasziou D. Reidlinger D. Cauchi S. Kersten B. Staels R. Ribeiro A. Renehan J. Dyck M. Hofker CE. Fonvig JT. Kloppenborg E. Chabanova M. Johansen I. Berre HS. Thomsen JC. Holm B. van der Kolk G. Goossens J Jocken E. Blaak P.A. Smeets H.R. Berthoud E. Qualls-Creekmore S. Yu C.D. Morrison H. Münzberg F. Rasmussen S. Ulijaszek C. Summerbell U. Pagotto M. Suter F. Anesten M. Holt V. Pálsdóttir F. Reimann C. Safari E. Schéle F. Gribble K. Skibicka S. Trapp JO. Jansson T. Christen S. Trompet KB. Gast PCN. Rensen JAP. Willems Van Dijk HJ. Lamb A. De Roos JW. Jukema FR. Rosendaal S. Le Cessie R. De Mutsert J.M. Brunstrom C. de Graaf S. Higgs M. Blüher J.K. Kramer J.C. Holm E.M.H. Mathus-Vliegen J. Mathers A. Bouloumié C. Dani D. Bauters I. Scroyen RH. Lijnen TQ. Lopez A. Planavila M. Peyrou R. Moure R. Cereijo AG. Navarro R. RIglesias M. Giralt F. Villarroya M. Löf C. Holmberg J. Chaplin T. Hillman C. Berg JL. Clarke MJ. Pallan ER. Lancashire P. Adab R. Byrne E. Jansen L Daniels H Syrad SA. Jebb A. Fildes CH. Llewellyn N. Langin, D.; Viguerie W. Ahrens R. Foraita C. Picó V. Pala L. Bogl W. Gwozdz RL. Kolotkin JR. Andersen MH. Zeller H. Noordam H. Rutter A. Hardman Charlotte Finlayson Graham Christiansen Paul Hebebrand Johannes C.G. Halford Jason E. Blundell John M. Ross B. Blumberg M. La Merrill M. Desai LA. Condon M. Caon R. Rashid J. Lakerveld MG. Matias de Pinho JM. Oppert H. Bardos H. Rutter JL. Baker A. Alberga C. Fleetwood S. Kirk XR. Salas JA. Swift A. Raben M. Fogelholm MS. Westerterp-Plantenga M. Drummen T. Adam E. Dorenbos A. Vreugdenhil D. Sluik E. Feskens W. Schlicht S. Hansen J. Thurn P. Nowicka K. Eli K. Sorjonen L. Mokoena A. Pietrobelli C. Flodmark M. S. Faith M. B. Queally E. Doherty F. Finucane C. O'neill L. K. Elsenburg N. Smidt A. C. Liefbroer A. Gram M. Rosenkilde J. Sallling Quist M. Bæk Petersen B. Stallknecht P. Böhme K. Legrand A. Y. Omorou L. Muller E. Lecomte M. Quinet L. Saez J. Langlois C. Pourcher C. Gailliard S. Briançon P. GROUP N. Döring A. Ghaderi B. Bohman B. Heitmann C. Larsson D. Berglind L. Hansson E. Sundblom M. Magnusson M. Blennow P. Tynelius L. Forsberg F. Rasmussen E. Robinson A. Sutin C. K. Nikolaou C. R. Hankey M. E. Lean E. Yuzbashian M. Zarkesh G. Asghari B. Mahmoodi M. Safarian M. Hedayati P. Mirmiran S. Heinonen M. Muniandy J. Buzkova A. Mardinoglu A. Hakkarainen J. Lundbom N. Lundbom J. Kaprio A. Rissanen K. H. Pietiläinen L.C. Dias V. Nobrega T.K. Weber R.M. Cintra N. R. Moreno Castellanos A. Rodríguez Y. Rabanal Ruiz J. López Miranda R. Vázquez Martínez G. Frühbeck M. Malagón M. M. Malagon R. Guzman-Ruiz Y. Rabanal R. El Bekay A. Trávez S. García Navarro F. Gracia Navarro J. López Miranda R. Vázquez Martínez F. J. Tinahones P. D. Petrov A. Palou M. Bonet J. Ribot R. Stinkens B. Brouwers J. Jocken M. Hesselink P. Schrauwen V. Liakopoulos A. Svensson S. Franzén I. Näslund J. Ottosson S. Gudbjörnsdottir B. Eliasson H. Konttinen M. Peltonen L. Sjöström L. Carlsson J. Karlsson P. Souteiro S. Belo J.S. Neves S.C. Oliveira R.B. Silva D. Magalhães A. Saavedra M.M. Costa F. Cunha J. Oliveira E. Lau C. Esteves J. Queirós A. Varela P. Freitas D. Carvalho G. Amtco J.A. Kerr C. Long S.A. Clifford J. Muller A.N. Hanvey M. Wake K.A. Ligthart W.D. Paulis B.W. Koes M. Van Middelkoop L. Croot M. Rimmer E. Dowse J. Harris C. Hatton S. Hillier J. Lavin A. O'cathain S. Salway I. Larsson S. Björkman H. Lantz B. Eliasson F. Jung C. Luck Sikorski H.H. König S. G. Riedel Heller C. Magnussen M. Buscot M. Sabin M. Juonala R. Thomson J. Viikari O. Raitakari F. Torres Espínola M. Arias M. Romero Sánchez M. García Bermúdez M. Escudero Marín M. Pérez García C. Campoy L.G. Bjerregaard M. Gamborg J.L. Baker B.W. Jensen M. Gamborg I. Gögenur T.I. Sørensen J.L. Baker K. Mehlig G. Eiben C. Galli P. Rise V. Krogh L. Lissner M. Bygdell C. Ohlsson J. Celind J. Saternus A. Sondén J.M. Kindblom L. Marryat T. Cole J. Mccoll U. Harjunmaa P. Ashorn C. Wright R. Bramsved S. Regber D. Novak K. Mehlig L. Lissner S. Mårild C. Malbert M. Genissel J. Georges F. Legouevec J. Divoux C. Picq L. Guillemetz C. Henry P.D. Petrov E.E. Canfora J.W. Jocken C.M. Van Der Beek Y.P. Essers N.T. Hoebers E.E. Blaak C. Malbert M. Genissel J. Georges F. Legouevec J.R. Ingram E.G. Walker M.C. Pahl K.R. Lo H.S. Shin C. Lang M.W. Wohlers S.D. Poppitt K.H. Sutton M. Hopkins C. Gibbons J.E. Blundell G. Finlayson S. Chakraborty K. Balanda I.J. Perry Z. Kabir T. Tanaka T. Sonoyama H. Sawada M. Inoue Y. Ogino T. Guo K. Nakao M. Luger R. Kruschitz C. Kienbacher S. Traussnigg F. Langer K. Schindler T. Würger F. Wrba F. Hoppichler M. Trauner G. Prager B. Ludvik P. Christensen M. Fogelholm M. Westerterp Plantenga I. Macdonald J. Martinez S. Handjiev J. Brand Miller S. Poppitt W. Schlicht A. Astrup K. Pietiläinen M. Drummen M. Taylor S. Navas Carretero T. Handjiev Darlenska S. Brodie M. Silvestre J. Thurn T. Larsen A. Raben B. Cabia S. Andrade M. Amil M. Carreira F. Casanueva A. Crujeiras G. Campanella R.J. Beeken H. Croker N. Finer M. Heinrich A.R. Leeds A. Obichere J. Wardle M.J. Gunter A. Morton H. Moore E.E. Moore

Basel · Freiburg · Paris · London · New York · Chennai · New Delhi · Bangkok · Beijing · Shanghai · Tokyo · Kuala Lumpur · Singapore · Sydney European Obesity Summit (EOS) – Joint Congress of EASO and IFSO-EC Gothenburg, Sweden, June 1 – 4, 2016

Journal: :Current trends in gastroenterology and hepatology 2022

Non-alcoholic fatty liver disease is not simply the hepatic manifestation of obesity and diabetes but also linked to hepatocellular carcinoma. Yet, its effective treatment has been established. In this study, we evaluated effect a short-term administration luseogliflozin patients with type 2 having non-alcohol disease. Luseogliflozin unique sodium-glucose cotransporter inhibitor which metaboliz...

2014
Elizabeth Wanless Lawrence W Judge Shannon T Dieringer David Bellar James Johnson Sheli Plummer

Childhood obesity affects 1 of every 6 youth in the United States. One contributing factor to this statistic is a lack of physical activity (PA). Demands related to accountability which are placed on educators to demonstrate academic achievement often result in resistance to allocating time during the school day for PA. One possible solution is to consider utilizing time after school to integra...

2014
So-Hyeon Baek Hea-Jong Chung Heui-Kwan Lee Roshan D'Souza Youngju Jeon Hyeon-Jin Kim Soon-Jong Kweon Seong-Tshool Hong

Obesity is the most prevalent disease in the world which poses a serious risk for various chronic diseases. However, currently there are not any therapeutic agents that reduce body weight without causing serious side effects. In order to prevent and/or treat obesity and related diseases through a nutraceutical approach, we created a resveratrol-enriched transgenic rice accumulating 1.4 μg/g of ...

Journal: :Diabetes care 2008
Owais B Chaudhri Katie Wynne Stephen R Bloom

The current obesity epidemic is fuelled by the availability of highly palatable, calorie-dense food, and the low requirement for physical activity in our modern environment. If energy intake exceeds energy use, the excess calories are stored as body fat. Although the body has mechanisms that act to maintain body weight over time, they primarily defend against starvation and are less robust in p...

Journal: :journal of research in medical sciences 0
elham hashemi dehkordi farnaz sattari abolfazl khoshdel karamali kasiri

background: considering the increasing trend of obesity, especially in developing countries such as iran, and the role of inflammatory factors and insulin resistance (ir) in the occurrence of obesity?related complications as well as the safety of some agents such as folic acid and metformin, this clinical trial was designed to investigate the effect of metformin and folic acid on inflammatory f...

Journal: :American journal of epidemiology 2015
Juan Pablo Rey-López Leandro Fornias de Rezende Thiago Hérick de Sá Emmanuel Stamatakis

Some obese persons do not develop (at least in the short term) the metabolic complications of obesity that are thought to be causally linked to cardiovascular events or premature mortality. This phenomenon has been termed "metabolically healthy obesity" (MHO), and it has received much attention recently, to the extent that some authors argue that "new metrics" must be developed to estimate the ...

Journal: :journal of herbal drugs (an international journal on medicinal herbs) 2015
alaleh nikooie amir pouya ghandehari yazdi mina shamsaei leila sedaghat boroujeni

background & aim:   changes in lifestyle, decrease in physical exercise along with incidence of obesity, hypertension and cardiovascular diseases indicate a need for low calorie formulations. the sweetness of stevia, a natural sweetener, is estimated to be 300 times as much as that of sugar. extraction of stevia leaves is considered a promoter of calorie balance and a beneficial part of a h...

Journal: :Lancet 2015
Terry T-K Huang John H Cawley Marice Ashe Sergio A Costa Leah M Frerichs Lindsey Zwicker Juan A Rivera David Levy Ross A Hammond Estelle V Lambert Shiriki K Kumanyika

Public mobilisation is needed to enact obesity-prevention policies and to mitigate reaction against their implementation. However, approaches in public health focus mainly on dialogue between public health professionals and political leaders. Strategies to increase popular demand for obesity-prevention policies include refinement and streamlining of public information, identification of effecti...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید